Shop Apotheke Europe (ETR:SAE) Given a €138.00 Price Target by Barclays Analysts

Barclays set a €138.00 ($145.26) price objective on Shop Apotheke Europe (ETR:SAE – Get Rating) in a report released on Tuesday morning, Borsen Zeitung reports.

Several other analysts have also recently issued reports on SAE. Berenberg Bank set a €125.00 ($131.58) price objective on Shop Apotheke Europe in a research note on Wednesday, March 9th. Kepler Capital Markets set a €70.00 ($73.68) price objective on Shop Apotheke Europe in a research note on Tuesday, January 11th. Hauck and Aufhaeuser set a €80.00 ($84.21) price target on Shop Apotheke Europe in a research note on Thursday, March 3rd. Warburg Research set a €144.00 ($151.58) price target on Shop Apotheke Europe in a research note on Thursday, May 5th. Finally, Baader Bank set a €100.00 ($105.26) price target on Shop Apotheke Europe in a research note on Thursday, May 5th.

Shares of ETR SAE opened at €91.86 ($96.69) on Tuesday. The stock has a market cap of $1.66 billion and a P/E ratio of -22.15. The company has a current ratio of 3.49, a quick ratio of 2.58 and a debt-to-equity ratio of 54.85. Shop Apotheke Europe has a 12-month low of €65.28 ($68.72) and a 12-month high of €182.00 ($191.58). The business’s fifty day simple moving average is €79.87 and its 200-day simple moving average is €106.61.

Shop Apotheke Europe Company Profile (Get Rating)

Shop Apotheke Europe N.V. owns and operates online pharmacies in Germany, Austria, Switzerland, France, Belgium, Italy, and the Netherlands. It provides prescription medications, over-the-counter medications, and pharmacy-related beauty and personal care products, as well as food supplements. The company was founded in 2001 and is headquartered in Sevenum, the Netherlands.

Featured Stories